New African Nation Reaches WHO Maturity Level 3 In Medicines Regulation
Zimbabwe's National Regulatory Authority has achieved Maturity Level 3 in line with WHO's global benchmarking tool.
Zimbabwe's National Regulatory Authority has achieved Maturity Level 3 in line with WHO's global benchmarking tool.
GSK has sold its remaining 4.2% Haleon shares formalizing its exit from the consumer healthcare division Haleon PLC.
A win for African Medicines Agency as yet another country signs the treaty. It is expected that this Agency will drive the improvement of Africa's pharma sector
Nigeria is rolling out the new meningitis vaccine (Men5CV) to fight against a disease that has claimed many lives in the region.
Gavi announced a total of 18 million malaria vaccine doses will be distributed to 12 African countries for the period between 2023-2025.
Daewoong Pharmaceutical’s Fexuprazan takes its first step into Africa Entering into a partnership with Cooper Pharma, in Morocco.
African pharmaceutical review understands that the Presidential taskforce in The Gambia conclusively links death of 70 children in the country to cough syrups.
In Nigeria Pfizer is seeking collaboration with key stakeholders on efforts to educate consumers about counterfeit medicines
MSF has raised concerns over new clauses introduced by ViiV Healthcare during their contract negotiations around cabotegravir, a new long acting HIV medicine.
South Africa has made a step forward in the fight against HIV with the implementation of the Pharmacist Initiated Management of Antiretroviral Therapy.
Cipla has acquired Actor Pharma, a company specialized in OTC and generic medicines in South Africa.
For more than 135 years, Johnson & Johnson (the “Company”) has provided health care products and solutions to people worldwide.
Dr Daniel Byamukama, head of the HIV prevention division at the Uganda Aids Commission (UAC) stated that there were plans to roll out the drug at the onset of January 2024.
The Parliament of the United Republic of Tanzania have ratified the African Medicines Agency Treaty. AMA is expected to enhance regulatory capacity in Africa.
The African Pharmaceutical Technology Foundation will begin its operations in earnest after the African Development Fund provided a grant.
In a strategic move, Pfizer plans to sell 630 million Haleon shares estimated to be worth £2 billion.
The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Rwanda Food and Drug Authority (Rwanda FDA).
In the last two years, if there is one thing that the Covid pandemic has taught us is that good inventory management practices are vital in shielding the pharmaceutical industry against unprecedented losses. These losses range from high financial losses since expired medicines can no longer be distributed to high disposal costs involved. The following are some of the best practices that pharmaceutical players can put in place and help mitigate losses particularly during the pandemic
Forecasting can be defined as the process of predicting sales and consumption of pharmaceuticals to allow purchase in appropriate quantities in advance.
A key building blocks of a good healthcare system is access to high-quality and affordable medication. In Kenya however there are great limitations
A report by WHO in 2022 showed that diseases such as HIV and Malaria in sub-Saharan Africa accounts for 85% and 95% of global HIV and malaria cases respectively. 73% of the estimated 1.6 million people who die annually from AIDS are Africans.
Counterfeit medicines are a huge challenge in Africa. 267000 people die annually in sub-Saharan Africa due to substandard or counterfeit anti-malarial medicines
African Pharma Industry can be shaped through leveraging on technology. Drug discovery, manufacturing, clinical trials and academia can all profit,
A new study has shown that a drug used in management of type 2 diabetes can lead to weight loss in patients who are obese or overweight.
The African Pharma Industry in 2023 was filled with some events that positively shaped the continent while some that showed challenges that are still abound.
There are initiatives (in this article referred to as the 3As) that have been launched in the continent by organizations such as the African Union (AU) aimed to revamp the African pharmaceutical sector.
When GSK’s CEO Emma Walmsley took over office from Andrew Witty in 2017, her strategy was clear; to create a more competitive operating model for the company’s business in emerging markets.
Many African National Medicines Regulatory Authorities (NRAs) aspire to reach WHO Maturity levels 3 and 4 but struggle to do so. Financing is a major hindrance.
Medical product recalls is a great strategy in post-market surveillance in ensuring a market only has quality, safe and efficacious health products.
Through local pharma manufacturing, Africa could unlock the full potential of Africa's pharmaceutical sector. How can it be done in a sustainable manner?
Published in the 11 April 2024 edition of Nature, “AI can help to tailor drugs for Africa – but Africans should lead the way” outlines how machine learning (ML) can improve our understanding of how therapeutics might affect patients of African descent.
The medicine pregabalin is fast becoming an emerging point of concern in the Niger and other parts of West Africa, a UNODC report highlights.
National Agency for Food and Drug Administration and Control (NAFDAC), is working with pharmaceutical companies to reduce high cost of medicines in Nigeria.
Africa Pooled Procurement Mechanism is a strategy poised to help improve affordability and accessibility of life saving medical products.
Counterfeit Medicines are a pervasive global challenge with Africa showing huge vulnerabilities that make it an easy prey for those involved.
In this second episode Bevin has a candid conversation with a Senior Antimicrobial Resistance Control Specialist who works at the East Central and Southern Africa Health Community- Dr. Evelyn Wesangula. Dr. Wesangula explains why Africa as a continent should be keen on the issue of antimicrobial resistance, the role of community pharmacies, a message to health workers & the general public among other discussion points.
In this episode Bevin sits down with a pharmacist who has extensive experience working in medically assisted therapy (MAT) clinics where heroin addicts are managed using doses of synthetic opioids such as Methadone, Dr. Elizabeth Muritu.
In this second episode Bevin has a candid conversation with a Senior Antimicrobial Resistance Control Specialist who works at the East Central and Southern Africa Health Community- Dr. Evelyn Wesangula.
We have an informative conversation with Dr. Tracie Muraya about antimicrobial resistance focusing on what can be done to mitigate its impact
In this interview we discuss with Dr. Christabel Khaemba, Head of Pharmacovigilance at the PPB, Kenya the role of pharmacovigilance in patient safety.
In this interview, Dr. Irene Chege talks to us about her efforts in research on traditional medicines, their quality, safety and efficacy.
Get pharma insights from this interview with Prof Faith Okalebo. An Associate Professor at the University of Nairobi, where she teaches Pharmacology.
Johnson & Johnson have agreed to drop the price of a critical WHO recommended TB drug in South Africa.
Pharmaceutical companies in Africa can leverage outsourcing to improve cost and operational efficiencies while gaining access to high level technical know-how.
The pre-clinical drug discovery market is costly, inefficient and ripe for disruption, even before the COVID-19 pandemic.
GSK announced "positive" results from a study comparing the efficacy of the 2-drug regimen dolutegravir/lamivudine (DTG/3TC) to the 3-drug regimen bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) in managing virologically-suppressed adults living with HIV after 48 weeks of therapy. Both regimens are administered as a single tablet per day.
Pharmaceutical supply chains are essential for the national and health security and economic prosperity of the United States, stated Janet Woodcock, the then-acting FDA Commissioner, in June 2021.
The National Medicines Regulatory Authority of Cote d’Ivoire, l'AIRP, has issued a rapid alert on CARVEDI-DENK (carvedilol) 25 mg tablets due to quality concerns.
The World Health Organization (WHO) has invited Mpox vaccine makers to submit expression of interest (EOI) and subsequently, dossiers for evaluation leading to Emergency Use Listing (EUL).
In this interview, Kirti Narsai discusses the role local production of pharmaceuticals in Africa may play in enhancing growth of the sector.
The Nigerian Regulatory Authority, the National Agency for Food and Drug Administration and Control (NAFDAC), issued five alerts in August regarding confirmed cases of counterfeit medicines in the market.
Nigeria has become the first country in the continent (excluding clinical trial regions) to receive vaccines against the Monkey pox virus (mpox).
Get all the top stories from Blogs to keep track.